IMX-110 in Patients With Advanced Solid Tumors

Clinical trial NCT03382340 · UNKNOWN

Trial details

NCT number: NCT03382340
Sponsor: Immix Biopharma Australia Pty Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Advanced Solid Tumors Pancreatic Cancer Breast Cancer Ovarian Cancer

Start date: 2018-02-15
Primary completion: 2023-10-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.